Featured
Importance:
Tinea Unguium (Onychomycosis) is most
often caused by Trichophyton rubrum and T. interdigitale. It should be
distinguished from other causes of onychomycosis:
Candida species, which often cause paronychia,
infection of skin around the nail.
Clinical features:
Tinea unguium is increasingly
prevalent with increas...
American Academy of Family Physicians (AAFP) Journal: Published on October 2021Onychomycosis is a chronic fungal
infection of the fingernail or toenail bed leading to brittle, discolored, and
thickened nails. Untreated onychomycosis can cause pain, discomfort, and
physical impairment, negatively impacting quality of life. Onychomycosis should be...
Indian Journal of Dermatology: Published on July, 2017Dermatophytosis are the most common
fungal infections globally. According to the World Health Organization, the
prevalence rate of superficial mycotic infection worldwide has been found to be
20%–25%. Hot and humid climate in the tropical and subtropical countries like Bangladesh
makes derma...
Dermatophytosis is the most
common superficial fungal infection worldwide. In recent years, superficial
mycoses have become increasingly resistant to current antifungals;
specifically, high incidences of chronic infection, reinfection, and treatment
failure have been reported. Therefore the importance of
detecting drug resistance in clinical p...
Tinea cruris, also known as jock
itch, is a fungal infection involving the genital, pubic, perineal, and
perianal skin caused by pathogenic fungi known as dermatophytes. Tinea cruris is commonly caused
by Trichophyton rubrum or T. mentagrophytes.Several risk factors have been
identified that predispose an individual to tinea cruris, including e...
PubMed Central: Published on January 2019Tinea (Pityriasis) Versicolor is a
common, chronic, superficial fungal infection caused by Malassezia spp.
It is characterised by hyperpigmented, hypopigmented macules and patches on the
face, upper trunk, back, chest paralleling the density of sebaceous gland. Several topical and systemic
antifungal age...
Journal of the European
Academy of Dermatology and Venereology (JEADV): Published on November, 2021Tinea capitis is a highly contagious scalp condition that is
common in children 3-7 years of age but can be found in all ages. It can
present with a spectrum ranging from scaly, patchy alopecia with or without
"blackdots" to purulent inflammation...
BioMed Central (BMC Dermatol) Journal: ECTODERM
IndiaSuperficial fungal infections are caused by dermatophytes,
non-dermatophytic moulds and commensal yeasts. Dermatophytes, the most common
causative agents, are assuming high significance in developing countries like
India.Currently, dermatologists across India are inundated with
cases of derm...
International Journal
of Research in Dermatology (IJORD): Published on May, 2021The number of
new cases of dermatophytosis on
the rise but also
a humungous number of
patients are experiencing
a great degree
of relapses and recurrences.
Causes like drug
resistance, poor drug compliance, inadequate...
Indian Journal of Dermatology: Published on July, 2020A Randomized Controlled Parallel
Group Open Labeled Trial with Clinico-Mycological Correlation.Tinea is a superficial fungal
infection caused by dermatophytes which invade and multiply within the
keratinized tissue (skin, hair, nails). Approximately 20%-25% of the world population
is affecte...
JAMA Dermatology: Published on September 28, 2022With worldwide emergence of recalcitrant and resistant
dermatophytosis, itraconazole is increasingly being used as the first-line drug
for treatment of tinea corporis/cruris (TCC). Apparent inadequacy with low doses has led to empirical use
of higher doses and antifungal combinations.This study ai...
FRONTLINE MEDICAL NEWS – Dr.
Boni E. Elewski.Luliconazole
(NULIZA ®) has something unique
to offer when it comes to treating tinea pedis. This is an azole drug, meaning
it is broad spectrum and kills dermatophytes, yeast, and molds. Also, like all
azoles, it has some antibacterial activity.
The generic Luliconazole
(NULIZA ®) is approved f...
